We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) FLUDARABIN ACTAVIS fludarabine 50mg/2mL (25 mg/mL), concentrate for solution for injection or infusion (Teva Sweden)
Section 19A approved medicine
(Approval lapsed) FLUDARABIN ACTAVIS fludarabine 50mg/2mL (25 mg/mL), concentrate for solution for injection or infusion (Teva Sweden)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
FLUDARABINE JUNO fludarabine phosphate 50mg powder for injection vial fludarabine phosphate 50mg - ARTG 147831
Indication(s)
Treatment of B-cell chronic lymphocytic leukaemia.
Images
